Cart
sales@molnova.com
CEF27,Epstein-Barr Virus BRLF-1 lytic 148-156
CAS No. 254110-79-7
CEF27,Epstein-Barr Virus BRLF-1 lytic 148-156( —— )
Catalog No. M29966 CAS No. 254110-79-7
HLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameCEF27,Epstein-Barr Virus BRLF-1 lytic 148-156
-
NoteResearch use only, not for human use.
-
Brief DescriptionHLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).
-
DescriptionHLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).(In Vitro):Expression of the EBV immediate-early (IE) protein BRLF1 induces the lytic form of viral replication in most EBV-positive cell lines.
-
In VitroExpression of the EBV immediate-early (IE) protein BRLF1 induces the lytic form of viral replication in most EBV-positive cell lines.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number254110-79-7
-
Formula Weight302.93
-
Molecular FormulaTKSVY2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Arg}{Val}{Arg}{Ala}{Tyr}{Thr}{Tyr}{Ser}{Lys}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Darr CD, et al. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J Virol. 2001 Jul;75(13):6135-42.
molnova catalog
related products
-
Milatuzumab
Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.
-
BPN14770
BPN14770 is an allosteric inhibitor of selective phosphodiesterase 4D (PDE4D; IC50s: 7.8 nM and 7.4 nM for PDE4D7 and PDE4D3).
-
MC-1-F2
MC-1-F2 is a direct FOXC2 inhibitor with anticancer activity, inhibits cancer stem cell (CSC) characteristics, and reduces the invasive ability of castration-resistant prostate cancer (CRPC) cell lines.
